SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook
14 references·1 citing·42 second hop
Integrating Economic Analysis Into Cancer Clinical Trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook (1998)Integrating Economic Analysis Into Cancer…Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods (1997)Confidence Intervals for Cost…Statistical Analysis in Pharmacoeconomic Studies (1996)Statistical Analysis in Pharm…Guidelines for authors and peer reviewers of economic submissions to the BMJ (1996)Guidelines for authors and pe…Estimating the costs attributable to a disease with application to ovarian cancer (1996)Estimating the costs attribut…ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL (1996)ESTIMATING CONFIDENCE INTERVA…Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem (1996)Confidence intervals for cost…A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials (1996)A Strategy for Collecting Pha…Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis (1995)Medicare Payments from Diagno…Statistical analysis of cost outcomes in a randomized controlled clinical trial (1994)Statistical analysis of cost …Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis (1993)Efficacy and Cost-Effectivene…Efficacy and Cost-effectiveness of Autologous Bone Marrow Transplantation in Metastatic Breast Cancer (1992)Efficacy and Cost-effectivene…The National Economic Burden of Cancer: An Update (1990)The National Economic Burden …Clinical Economics (1989)Clinical EconomicsHealth Care Financing Review (1980)Health Care Financing ReviewIs the EQ-5D suitable for use in oncology? An overview of the literature and recent developments (2016)Is the EQ-5D suitable for use…Methods for the economic evaluation of health care programmes (1987)Quality of life and pharmacoeconomics in clinical trials (1996)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)The Markov Process in Medical Prognosis (1983)A Clinician's Guide to Cost-Effectiveness Analysis (1990)Setting Health Care Priorities in Oregon (1991)Markov Models in Medical Decision Making (1993)Cost-effectiveness of captopril therapy after myocardial infarction (1995)A Cost-Effectiveness Analysis of Adjuvant Trastuzumab Regimens in Early HER2/neu–Positive Breast Cancer (2007)A Comparison of Alternative Models for the Demand for Medical Care (1983)Economic Analysis Alongside Clinical Trials: Revisiting the Methodological Issues (1991)Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis (1998)Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee. (1999)The estimation of a preference-based measure of health from the SF-36 (2002)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)Utility approach to measuring health-related quality of life (1987)Cost-Effectiveness and Cost-Benefit Analyses in the Medical Literature (1992)Uncertainty in the economic evaluation of health care technologies: The role of sensitivity analysis (1994)Multi-Attribute Preference Functions (1995)Clinical decision analysis (2005)Costs, effects and C/E‐ratios alongside a clinical trial (1994)In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care (1994)The Distribution of Health Care Costs and Their Statistical Analysis for Economic Evaluation (1998)Pharmacoeconomic Evaluation in the Real World (1999)Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods (2002)Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 (1998)Definition, interpretation and calculation of cost-effectiveness acceptability curves (2000)Assessing the costs of healthcare technologies in clinical trials. (1999)Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation (1999)Regression models for analyzing costs and their determinants in health care: an introductory review (2011)Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer (1995)Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer. (1998)The effectiveness of cost-effectiveness analysis in containing costs (1998)The Burden of Illness of Cancer: Economic Cost and Quality of Life (2001)Clinical model of lifetime cost of treating bladder cancer and associated complications (2006)Time costs associated with informal caregiving for cancer survivors (2009)Medical Care Costs: How Much Welfare Loss? (1992)Cross-Disability Experiences of Barriers to Health-Care Access (2006)The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms (2007)
this work references cited by second hop

References

  • 1996Guidelines for authors and peer reviewers of economic submissions to the BMJ1,828 cited
  • 1989Clinical Economics689 cited
  • 1980Health Care Financing Review425 cited
  • 1995Medicare Payments from Diagnosis to Death for Elderly Cancer Patients by Stage at Diagnosis332 cited
  • 1996ESTIMATING CONFIDENCE INTERVALS FOR COST-EFFECTIVENESS RATIOS: AN EXAMPLE FROM A RANDOMIZED TRIAL313 cited
  • 1997Confidence Intervals for Cost-Effectiveness Ratios: A Comparison of Four Methods282 cited
  • 1996Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem189 cited
  • 1993Efficacy and Cost-Effectiveness of Cancer Treatment: Rational Allocation of Resources Based on Decision Analysis162 cited
  • 1992Efficacy and Cost-effectiveness of Autologous Bone Marrow Transplantation in Metastatic Breast Cancer139 cited
  • 1994Statistical analysis of cost outcomes in a randomized controlled clinical trial111 cited
  • 1996Estimating the costs attributable to a disease with application to ovarian cancer92 cited
  • 1990The National Economic Burden of Cancer: An Update63 cited
  • 1996Statistical Analysis in Pharmacoeconomic Studies53 cited
  • 1996A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials50 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

Cited by

  • 2016Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments48 cited